Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calpain-2 catalytic subunit is a calcium-dependent cysteine protease that plays a role in various cellular processes, including cytoskeletal remodeling, signal transduction, and apoptosis. It is implicated in several diseases, including cardiac disease, hepatic fibrosis, and neurodegenerative disorders. The enzyme is activated by calcium binding and undergoes autolytic processing, and its activity is regulated by the endogenous inhibitor calpastatin. Targeting CAPN2 may present therapeutic challenges due to its broad substrate specificity and essential physiological functions.
Calpain-2 is a calcium-dependent cysteine protease involved in limited proteolysis of various substrates. Drugs targeting this molecule typically aim to inhibit its proteolytic activity, preventing its involvement in disease-related pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calpain-2 Catalytic Subunit (CAPN2).